$CING 8-K SEC Filings

Filed On	Filing
02 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers This AMENDMENT NO. 2 is made and effective as of September 30, 2026 by and between CINGULATE THERAPEUTICS LLC, a Delaware Limited Liability Company, whose principal address is 1901 W. 47th Place, 3rd Floor, Kansas City, KS 66205 (the “Co...
13 Aug 2026	8-K: Results of Operations and Financial Condition
23 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation
14 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
02 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
16 Jun 2026	8-K: Regulation FD Disclosure
02 Jun 2026	8-K: Regulation FD Disclosure; Other Events
19 May 2026	8-K: Departure/Election of Directors or Officers; Compensation
14 May 2026	8-K: Results of Operations and Financial Condition
02 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation
24 Mar 2026	8-K: Entry into a Material Definitive Agreement; Submission of Matters to a Vote of Security Holders
18 Mar 2026	8-K: Results of Operations and Financial Condition; Other Events
17 Feb 2026	8-K: Unregistered Sales of Equity Securities; Departure/Election of Directors or Officers; Compensation +2 more
06 Feb 2026	8-K: Unregistered Sales of Equity Securities; Other Events
28 Jan 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
15 Jan 2026	8-K: Other Events
02 Jan 2026	8-K: Unregistered Sales of Equity Securities
15 Dec 2025	8-K: Departure/Election of Directors or Officers; Compensation
13 Nov 2025	8-K: Results of Operations and Financial Condition
10 Nov 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more

Comments